Plavix sNDA Granted Priority Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol-Myers Squibb's and Sanofi-Aventis' anti-thrombotic Plavix (clopidogrel bisulfate) will have a user fee date of May 17, 2006 under a six-month priority review